https://stock.noler.com/us/stock/yew-bio-pharm-group-inc https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-payable https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-receivable https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-receivable-gross-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-receivable-related-parties https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accrued-income-taxes https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accrued-income-taxes-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accrued-rent-current-and-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accumulated-depreciation https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/additional-paid-in-capital https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/additions-to-noncurrent-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/adjustment-for-amortization https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/adjustment-to-additional-paid-in-capital-income-tax-effect-from-share-based-compensation-net https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/advertising-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/amortization https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/aoci https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/assets-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/basic-shares https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/business-acquisition-purchase-price-allocation-land https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/capital-expenditures https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/cash-and-equivalents https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/cash-flow-breakdown https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/cash-uninsured-amount https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/common-stock-value https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/comprehensive-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/concentration-risk-percentage https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/construction-payable-current-and-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/cost-of-revenue https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/cost-of-revenue-2 https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/costs-and-expenses-related-party https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/current-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/current-liabilities https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/customer-advances-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/debt-decrease-forgiveness https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/debt-face-amount https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/deferred-income-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/depreciation https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/diluted-shares https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/dilutive-shares https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/discontinued-operation-equity-method-investment-retained-after-disposal-ownership-interest-after-disposal https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/discontinued-operation-equity-method-investment-retained-after-disposal-ownership-interest-prior-to-disposal https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/due-from-related-parties https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/due-from-related-parties-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/due-from-related-parties-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/due-to-other-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/due-to-related-parties-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/effective-tax-rate https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/eps https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/eps-basic https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/financing-cash-flow https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/foreign-earnings https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/general-and-administrative-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/grants-receivable https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/gross-profit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/income-loss-from-extraordinary-items-tax-effect-per-basic-share https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/income-loss-from-extraordinary-items-tax-effect-per-diluted-share https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/income-tax https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/income-tax-expense-benefit-government-grants https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/income-taxes-paid https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-customer-advances https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-loans-deferred-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-notes-payable-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-payables-to-customers https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-prepaid-rent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/incremental-common-shares-attributable-to-contingently-issuable-shares https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/intangible-assets-net-including-goodwill https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/interest-expense-borrowings https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/interest-expense-other https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/interest-expense-short-term-borrowings https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/interest-income-expense-net https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/interest-paid https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/interest-paid-net https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/interest-portion-of-minimum-lease-payments-sale-leaseback-transactions https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/inventory https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/inventory-finished-goods https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/inventory-gross https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/inventory-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/inventory-raw-materials https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/inventory-work-in-process https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/inventory-write-down https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/investing-cash-flow https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/investment-income-interest https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/investment-options-exercise-price https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/land https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/lease-and-rental-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/lease-cost https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/liabilities-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/line-of-credit-facility-average-outstanding-amount https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/minority-interest https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/net-change-in-cash https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/net-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/notes-payable-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/number-of-operating-segments https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/number-of-reportable-segments https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-cash-flow https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-expenses https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-cost https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-liability https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-liability-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-cost-of-operating-revenue https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-current-liabilities https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-depreciation-and-amortization https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-inventory-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-noncash-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-nonoperating-gains-losses https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-nonoperating-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-operating-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/other-sales-revenue-net https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/payments-for-previous-acquisition https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/payments-for-purchase-of-other-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/payments-for-rent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/payments-to-acquire-land-held-for-use https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/payments-to-acquire-loans-receivable https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/payments-to-acquire-mining-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/preferred-shares-facts https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/prepaid-rent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/present-value-of-future-minimum-lease-payments-sale-leaseback-transactions https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/pretax-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/proceeds-from-collection-of-longterm-loans-to-related-parties https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/profit-loss https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/property-plant-equipment https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/public-float https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/related-parties-amount-in-cost-of-sales https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/related-party-transaction-due-from-to-related-party-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/related-party-transaction-purchases-from-related-party https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/repayment-of-notes-receivable-from-related-parties https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/research-and-development https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/retained-earnings https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/revenue https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/revenue-from-related-parties https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/salaries-and-wages https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/sales-revenue-goods-gross https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/secured-debt https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/segment-reporting-information-net-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/selling-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/sga-expense https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/share-price https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/shareholders-equity https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/shares-authorized https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/shares-issued https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/short-term-bank-loans-and-notes-payable https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/short-term-borrowings https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/statutory-accounting-practices-statutory-capital-and-surplus-balance https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-award-award-vesting-rights-percentage https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-based-compensation https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-granted-value-share-based-compensation-gross https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-cuts-and-jobs-act-income-tax-expense-benefit https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-rate-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-rate-reconciliation-tax-cuts-and-jobs-act-transition-tax-on-accumulated-foreign-earnings-amount https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/tax-rate-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/taxes-payable-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/taxes-payable-current-and-noncurrent https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/total-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/total-liabilities https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/valuation-allowance-amount https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/value-added-tax-receivable https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/value-added-tax-receivable-current https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/variable-interest-entity-consolidated-carrying-amount-assets https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/variable-interest-entity-consolidated-carrying-amount-liabilities https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/yew-bio-pharm-group-inc/workers-compensation-liability-current